相关实验视频
Updated: Jun 17, 2025

Translational Orthotopic Models of Glioblastoma Multiforme
Published on: February 17, 2023
通过调节EGFR稳定性,TSPAN4会影响质母细胞瘤的进展
Yanbin Dong1,2, Xiaolong Tang3, Wenhui Zhao4
1Department of Clinical Laboratory, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong 250117, China.
素4 (TSPAN4) 通过稳定表皮生长因子受体 (EGFR) 来促进质母细胞瘤 (GBM) 的进展. 高TSPAN4表达与不良的GBM预后相关,这表明TSPAN4是潜在的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 质母细胞瘤 (GBM) 由于高死亡率和低治愈率,在治疗方面存在重大挑战.
- 松素4 (TSPAN4) 被确定为一个迁移体标记物,但其在癌症,特别是GBM中的作用尚不清楚.
研究的目的:
- 研究TSPAN4在质母细胞瘤进展中的作用.
- 阐明TSPAN4影响GBM生长和入侵的分子机制.
主要方法:
- 在临床GBM样本中分析TSPAN4表达.
- 在体外研究涉及TSPAN4敲击和过度表达在GBM细胞.
- 在体内瘤发生性测定.
- 研究TSPAN4与表皮生长因子受体 (EGFR) 和下游信号通路的相互作用.
主要成果:
- TSPAN4在GBM中表达高,并与患者预后不佳有关.
- TSPAN4的淘汰抑制了GBM细胞的增殖,入侵和瘤性.
- TSPAN4与EGFR相互作用,调节其稳定性并禁用下游通路 (MEK/ERK,STAT3,AKT).
结论:
- 通过增强EGFR稳定性,TSPAN4显著促进GBM的进展.
- TSPAN4代表了质母细胞瘤治疗的潜在治疗点.
更多相关视频
05:45Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections
Published on: July 31, 2017
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
相关概念视频
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
TGF - β Signaling Pathway
Mitogens and the Cell Cycle
Regulation of Angiogenesis and Blood Supply
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...